These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 32328818)

  • 1. Human Colon Organoids and Other Laboratory Strategies to Enhance Patient Treatment Selection.
    Johnson KA; DeStefanis RA; Emmerich PB; Grogan PT; Kratz JD; Makkar SK; Clipson L; Deming DA
    Curr Treat Options Oncol; 2020 Apr; 21(5):35. PubMed ID: 32328818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity.
    Tanaka N; Osman AA; Takahashi Y; Lindemann A; Patel AA; Zhao M; Takahashi H; Myers JN
    Oral Oncol; 2018 Dec; 87():49-57. PubMed ID: 30527243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medium-throughput Drug Screening of Patient-derived Organoids from Colorectal Peritoneal Metastases to Direct Personalized Therapy.
    Narasimhan V; Wright JA; Churchill M; Wang T; Rosati R; Lannagan TRM; Vrbanac L; Richardson AB; Kobayashi H; Price T; Tye GXY; Marker J; Hewett PJ; Flood MP; Pereira S; Whitney GA; Michael M; Tie J; Mukherjee S; Grandori C; Heriot AG; Worthley DL; Ramsay RG; Woods SL
    Clin Cancer Res; 2020 Jul; 26(14):3662-3670. PubMed ID: 32376656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-Derived Cancer Organoid Cultures to Predict Sensitivity to Chemotherapy and Radiation.
    Pasch CA; Favreau PF; Yueh AE; Babiarz CP; Gillette AA; Sharick JT; Karim MR; Nickel KP; DeZeeuw AK; Sprackling CM; Emmerich PB; DeStefanis RA; Pitera RT; Payne SN; Korkos DP; Clipson L; Walsh CM; Miller D; Carchman EH; Burkard ME; Lemmon KK; Matkowskyj KA; Newton MA; Ong IM; Bassetti MF; Kimple RJ; Skala MC; Deming DA
    Clin Cancer Res; 2019 Sep; 25(17):5376-5387. PubMed ID: 31175091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Budget-Friendly Generation, Biochemical Analyses, and Lentiviral Transduction of Patient-Derived Colon Organoids.
    Rigaux E; Chen JW; George F; Lemaire J; Bertrand C; Faugeras L; Fattaccioli A; Gilliaux Q; D'Hondt L; Michiels C; Renard HF; Zanin N
    Curr Protoc; 2023 Dec; 3(12):e943. PubMed ID: 38058263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput screening in colorectal cancer tissue-originated spheroids.
    Kondo J; Ekawa T; Endo H; Yamazaki K; Tanaka N; Kukita Y; Okuyama H; Okami J; Imamura F; Ohue M; Kato K; Nomura T; Kohara A; Mori S; Dan S; Inoue M
    Cancer Sci; 2019 Jan; 110(1):345-355. PubMed ID: 30343529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study.
    Votanopoulos KI; Mazzocchi A; Sivakumar H; Forsythe S; Aleman J; Levine EA; Skardal A
    Ann Surg Oncol; 2019 Jan; 26(1):139-147. PubMed ID: 30414038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling colorectal cancer: A bio-resource of 50 patient-derived organoid lines.
    Engel RM; Jardé T; Oliva K; Kerr G; Chan WH; Hlavca S; Nickless D; Archer SK; Yap R; Ranchod P; Bell S; Niap A; Koulis C; Chong A; Wilkins S; Dale TC; Hollins AJ; McMurrick PJ; Abud HE
    J Gastroenterol Hepatol; 2022 May; 37(5):898-907. PubMed ID: 35244298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic heterogeneity of 2D organoid reflects clinical tumor characteristics.
    Fujino S; Ito A; Ohue M; Yasui M; Mizushima T; Doki Y; Mori M; Miyoshi N
    Biochem Biophys Res Commun; 2019 May; 513(2):332-339. PubMed ID: 30955861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids.
    Schuster B; Junkin M; Kashaf SS; Romero-Calvo I; Kirby K; Matthews J; Weber CR; Rzhetsky A; White KP; Tay S
    Nat Commun; 2020 Oct; 11(1):5271. PubMed ID: 33077832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plocabulin Displays Strong Cytotoxic Activity in a Personalized Colon Cancer Patient-Derived 3D Organoid Assay.
    Costales-Carrera A; Fernández-Barral A; Bustamante-Madrid P; Guerra L; Cantero R; Barbáchano A; Muñoz A
    Mar Drugs; 2019 Nov; 17(11):. PubMed ID: 31752287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-derived tumor models: a more suitable tool for pre-clinical studies in colorectal cancer.
    Rizzo G; Bertotti A; Leto SM; Vetrano S
    J Exp Clin Cancer Res; 2021 Jun; 40(1):178. PubMed ID: 34074330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol for generation of and high-throughput drug testing with patient-derived colorectal cancer organoids.
    Tan T; Mouradov D; Gibbs P; Sieber OM
    STAR Protoc; 2024 Jun; 5(2):103090. PubMed ID: 38809757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine.
    Praharaj PP; Bhutia SK; Nagrath S; Bitting RL; Deep G
    Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):117-127. PubMed ID: 29360544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Sensitivity Assays of Human Cancer Organoid Cultures.
    Francies HE; Barthorpe A; McLaren-Douglas A; Barendt WJ; Garnett MJ
    Methods Mol Biol; 2019; 1576():339-351. PubMed ID: 27628132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assay Establishment and Validation of a High-Throughput Screening Platform for Three-Dimensional Patient-Derived Colon Cancer Organoid Cultures.
    Boehnke K; Iversen PW; Schumacher D; Lallena MJ; Haro R; Amat J; Haybaeck J; Liebs S; Lange M; Schäfer R; Regenbrecht CR; Reinhard C; Velasco JA
    J Biomol Screen; 2016 Oct; 21(9):931-41. PubMed ID: 27233291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Patient-Derived Gastric Cancer Organoids from Endoscopic Biopsies and Surgical Tissues.
    Gao M; Lin M; Rao M; Thompson H; Hirai K; Choi M; Georgakis GV; Sasson AR; Bucobo JC; Tzimas D; D'Souza LS; Buscaglia JM; Davis J; Shroyer KR; Li J; Powers S; Kim J
    Ann Surg Oncol; 2018 Sep; 25(9):2767-2775. PubMed ID: 30003451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine.
    Pamarthy S; Sabaawy HE
    Mol Cancer; 2021 Sep; 20(1):125. PubMed ID: 34587953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective derivation of a living organoid biobank of colorectal cancer patients.
    van de Wetering M; Francies HE; Francis JM; Bounova G; Iorio F; Pronk A; van Houdt W; van Gorp J; Taylor-Weiner A; Kester L; McLaren-Douglas A; Blokker J; Jaksani S; Bartfeld S; Volckman R; van Sluis P; Li VS; Seepo S; Sekhar Pedamallu C; Cibulskis K; Carter SL; McKenna A; Lawrence MS; Lichtenstein L; Stewart C; Koster J; Versteeg R; van Oudenaarden A; Saez-Rodriguez J; Vries RG; Getz G; Wessels L; Stratton MR; McDermott U; Meyerson M; Garnett MJ; Clevers H
    Cell; 2015 May; 161(4):933-45. PubMed ID: 25957691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling neoplastic disease with spheroids and organoids.
    Zanoni M; Cortesi M; Zamagni A; Arienti C; Pignatta S; Tesei A
    J Hematol Oncol; 2020 Jul; 13(1):97. PubMed ID: 32677979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.